Ranbaxy Recalls Gebapentin Tablets

In a setback to pharmaceutical major Ranbaxy Laboratories Ltd., the U.S. drug regulator USFDA has directed the company to recall as many as 7.32 crore (73.2 million) Gebapentin tablets of 600 and 800 mg strengths.
Rediff